Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Disease × fluciclovine F-18 × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Brain Neoplasms 3 Urogenital Diseases 2 Neoplasms 2 Recurrence 1 Prostate Adenocarcinoma 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Glioblastoma 1 Disease 1

Interventions

Prednisone 3 Melphalan 2 Cytarabine 2 venetoclax 1 pembrolizumab 1 ofatumumab 1 obinutuzumab 1 ioflupane 1 ibrutinib 1 gossypol acetic acid 1 gilteritinib 1 fluorocholine 1 fluciclovine F-18 1 deltacortene 1 daratumumab 1 aflibercept 1 abiraterone 1 Temozolomide 1 Quality of Life 1 Paclitaxel 1 Oncolytic Virotherapy 1 Octreotide 1 Mitoxantrone 1 Methylene Blue 1 Lenalidomide 1 Gemtuzumab 1 Gemcitabine 1 Food 1 Fluorodeoxyglucose F18 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04410367 2025-07-20

PURSUE

Blue Earth Diagnostics

Phase 2 Completed

23 enrolled 10 charts

Brain Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡